Literature DB >> 19396340

Juvenile myoclonic epilepsy: more trials are needed to guide therapy.

Bassel W Abou-Khalil.   

Abstract

Entities:  

Year:  2009        PMID： 19396340      PMCID： PMC2668107          DOI： 10.1111/j.1535-7511.2008.01274.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  9 in total

1.  Juvenile myoclonic epilepsy of Janz.

Authors:  A V Delgado-Escueta; F Enrile-Bacsal
Journal:  Neurology       Date:  1984-03       Impact factor: 9.910

2.  Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.

Authors:  S Noachtar; E Andermann; P Meyvisch; F Andermann; W B Gough; J Schiemann-Delgado
Journal:  Neurology       Date:  2008-02-19       Impact factor: 9.910

3.  Clinical factors of drug resistance in juvenile myoclonic epilepsy.

Authors:  P Gelisse; P Genton; P Thomas; M Rey; J C Samuelian; C Dravet
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-02       Impact factor: 10.154

4.  Juvenile myoclonic epilepsy: a 5-year prospective study.

Authors:  C P Panayiotopoulos; T Obeid; A R Tahan
Journal:  Epilepsia       Date:  1994 Mar-Apr       Impact factor: 5.864

5.  Levetiracetam treatment of idiopathic generalised epilepsy.

Authors:  Gregory L Krauss; Tim Betts; Bassel Abou-Khalil; Gregory Gergey; Helen Yarrow; Akemi Miller
Journal:  Seizure       Date:  2003-12       Impact factor: 3.184

6.  Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.

Authors:  Avinash Prasad; Ruben I Kuzniecky; Robert C Knowlton; Tim E Welty; Roy C Martin; M Mendez; Raymond E Faught
Journal:  Arch Neurol       Date:  2003-08

7.  Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy.

Authors:  S F Berkovic; R C Knowlton; R F Leroy; J Schiemann; U Falter
Journal:  Neurology       Date:  2007-07-11       Impact factor: 9.910

8.  Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up.

Authors:  Iris E Martínez-Juárez; María Elisa Alonso; Marco T Medina; Reyna M Durón; Julia N Bailey; Minerva López-Ruiz; Ricardo Ramos-Ramírez; Lourdes León; Gregorio Pineda; Ignacio Pascual Castroviejo; Rene Silva; Lizardo Mija; Katerina Perez-Gosiengfiao; Jesús Machado-Salas; Antonio V Delgado-Escueta
Journal:  Brain       Date:  2006-03-06       Impact factor: 13.501

9.  The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321
  9 in total
  1 in total

1.  Upper cervical chiropractic care for a 25-year-old woman with myoclonic seizures.

Authors:  Todd A Hubbard; Casey A Crisp; Brett Vowles
Journal:  J Chiropr Med       Date:  2010-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.